Qiagen NV Given “Equal Weight” Rating at Barclays (QGEN)
Qiagen NV (NASDAQ:QGEN)‘s stock had its “equal weight” rating reaffirmed by equities researchers at Barclays in a research report issued on Tuesday. They currently have a $24.00 target price on the stock, up from their previous target price of $19.00. Barclays’ price target would suggest a potential downside of 0.41% from the stock’s previous close.
A number of other analysts have also recently weighed in on QGEN. Analysts at Wedbush raised their price target on shares of Qiagen NV from $19.00 to $20.00 in a research note on Thursday, July 31st. They now have a “neutral” rating on the stock. Separately, analysts at Jefferies Group raised their price target on shares of Qiagen NV from $19.00 to $23.00 in a research note on Thursday, July 31st. Finally, analysts at Leerink Swann raised their price target on shares of Qiagen NV from $24.00 to $26.00 in a research note on Thursday, July 31st. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the company. Qiagen NV presently has an average rating of “Hold” and an average target price of $24.63.
Shares of Qiagen NV (NASDAQ:QGEN) traded down 0.58% on Tuesday, hitting $23.96. 679,766 shares of the company’s stock traded hands. Qiagen NV has a 52-week low of $19.46 and a 52-week high of $25.32. The stock’s 50-day moving average is $24.55 and its 200-day moving average is $22.65. The company has a market cap of $5.575 billion and a P/E ratio of 43.58.
Qiagen NV (NASDAQ:QGEN) last announced its earnings results on Tuesday, July 29th. The company reported $0.26 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.25 by $0.01. The company had revenue of $331.20 million for the quarter, compared to the consensus estimate of $330.76 million. During the same quarter in the prior year, the company posted $0.27 earnings per share. The company’s quarterly revenue was up 4.7% on a year-over-year basis. Analysts expect that Qiagen NV will post $1.08 EPS for the current fiscal year.
QIAGEN N.V., (NASDAQ:QGEN) is a holding company, which provides sample and assay technologies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.